Skip to main content
logo
Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.170
-0.030 (-2.50%)
Sep 29, 2026, 4:00 PM EDT - Market closed

Cardiff Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-40.05-45.85-45.43-41.44-38.7-28.29
Depreciation & Amortization
0.890.90.940.40.240.45
Loss (Gain) From Sale of Assets
----00
Loss (Gain) From Sale of Investments
-0.57-0.85-0.6-0.920.631.61
Stock-Based Compensation
5.235.694.764.514.263.23
Other Operating Activities
----0.141.75
Change in Accounts Receivable
0.340.59-0.480.48-0.24-0.22
Change in Accounts Payable
-6.352.22.992.831.350.72
Change in Other Net Operating Assets
-0.34-0.610.133.25-1.49-2.29
Operating Cash Flow
-40.85-37.92-37.69-30.89-33.82-23.04
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.06-0.04-0.08-0.58-1.01-0.21
Investment in Securities
36.51.3913.8136.7839.04-131.24
Other Investing Activities
----0.11-
Investing Cash Flow
36.441.3413.7336.238.15-131.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
2.92.5853.78-0.0836.26
Other Financing Activities
-0.06-----0.81
Financing Cash Flow
2.832.5853.78-0.0835.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-1.59-3429.825.314.4-119.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-40.92-37.97-37.77-31.47-34.83-23.25
Free Cash Flow Growth
------
Free Cash Flow Margin
-8054.33%-6402.53%-5530.45%-6448.57%-9022.28%-6474.93%
Free Cash Flow Per Share
-0.60-0.57-0.79-0.70-0.80-0.60
Levered Free Cash Flow
-24.3-19.62-22.53-18.01-21.04-16.74
Unlevered Free Cash Flow
-24.3-19.62-22.53-18.01-21.04-16.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
000-00
Change in Working Capital
-6.352.182.636.57-0.38-1.79
SEC Filings: 10-K · 10-Q